Cargando…

Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital

INTRODUCTION: Rheumatic heart disease (RHD) frequently occurs following recurrent episodes of acute rheumatic fever (ARF). Benzathine penicillin (benzapen) is the most effective method for secondary prophylaxis against ARF whose efficacy largely depends on adherence to treatment. Various factors det...

Descripción completa

Detalles Bibliográficos
Autores principales: Musoke, Charles, Mondo, Charles Kiiza, Zhang, Wanzhu, Freers, Juergen, Okello, Emmy, Kakande, Barbara, Nyakoojo, Wilson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721822/
https://www.ncbi.nlm.nih.gov/pubmed/24217043
http://dx.doi.org/10.5830/CVJA-2013-022
_version_ 1782278093604388864
author Musoke, Charles
Mondo, Charles Kiiza
Zhang, Wanzhu
Freers, Juergen
Okello, Emmy
Kakande, Barbara
Nyakoojo, Wilson
author_facet Musoke, Charles
Mondo, Charles Kiiza
Zhang, Wanzhu
Freers, Juergen
Okello, Emmy
Kakande, Barbara
Nyakoojo, Wilson
author_sort Musoke, Charles
collection PubMed
description INTRODUCTION: Rheumatic heart disease (RHD) frequently occurs following recurrent episodes of acute rheumatic fever (ARF). Benzathine penicillin (benzapen) is the most effective method for secondary prophylaxis against ARF whose efficacy largely depends on adherence to treatment. Various factors determine adherence to therapy but there are no data regarding current use of benzapen in patients with RHD attending Mulago Hospital. The study aims were (1) to determine the levels of adherence with benzapen prophylaxis among rheumatic heart disease patients in Mulago Hospital, and (2) establish the patient factors associated with adherence and, (3) establish the reasons for missing monthly benzathine penicillin injections. METHODS: This was a longitudinal observational study carried out in Mulago Hospital cardiac clinics over a period of 10 months; 95 consecutive patients who satisfied the inclusion criteria were recruited over a period of four months and followed up for six months. Data on demographic characteristics and disease status were collected by means of a standardised questionnaire and a card to document the injections of benzapen received. RESULTS: Most participants were female 75 (78.9%). The age range was five to 55 years, with a mean of 28.1 years (SD 12.2) and median of 28 years. The highest education level was primary school for most patients (44, 46.3%) with eight (8.4%) of the patients being illiterate. Most were either NYHA stage II (39, 41.1%) or III (32, 33.7%). Benzathine penicillin adherence: 44 (54%) adhered to the monthly benzapen prophylaxis, with adherence rates ≥ 80%; 38 (46%) patients were classified as non-adherent to the monthly benzapen, with rates less than 80%. The mean adherence level was 70.12% (SD 29.25) and the median level was 83.30%, with a range of 0–100%; 27 (33%) patients had extremely poor adherence levels of ≤ 60%. Factors associated with adherence: higher education status, residing near health facility favoured high adherence, while painful injection was a major reason among poor performers. CONCLUSION: The level of non-adherence was significantly high (46%). Residence in a town/city and having at least a secondary level of education was associated with better adherence, while the painful nature of the benzapen injections and lack of transport money to travel to the health centre were the main reasons for non-adherence among RHD patients in Mulago.
format Online
Article
Text
id pubmed-3721822
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Clinics Cardive Publishing
record_format MEDLINE/PubMed
spelling pubmed-37218222013-08-07 Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital Musoke, Charles Mondo, Charles Kiiza Zhang, Wanzhu Freers, Juergen Okello, Emmy Kakande, Barbara Nyakoojo, Wilson Cardiovasc J Afr Cardiovascular Topics INTRODUCTION: Rheumatic heart disease (RHD) frequently occurs following recurrent episodes of acute rheumatic fever (ARF). Benzathine penicillin (benzapen) is the most effective method for secondary prophylaxis against ARF whose efficacy largely depends on adherence to treatment. Various factors determine adherence to therapy but there are no data regarding current use of benzapen in patients with RHD attending Mulago Hospital. The study aims were (1) to determine the levels of adherence with benzapen prophylaxis among rheumatic heart disease patients in Mulago Hospital, and (2) establish the patient factors associated with adherence and, (3) establish the reasons for missing monthly benzathine penicillin injections. METHODS: This was a longitudinal observational study carried out in Mulago Hospital cardiac clinics over a period of 10 months; 95 consecutive patients who satisfied the inclusion criteria were recruited over a period of four months and followed up for six months. Data on demographic characteristics and disease status were collected by means of a standardised questionnaire and a card to document the injections of benzapen received. RESULTS: Most participants were female 75 (78.9%). The age range was five to 55 years, with a mean of 28.1 years (SD 12.2) and median of 28 years. The highest education level was primary school for most patients (44, 46.3%) with eight (8.4%) of the patients being illiterate. Most were either NYHA stage II (39, 41.1%) or III (32, 33.7%). Benzathine penicillin adherence: 44 (54%) adhered to the monthly benzapen prophylaxis, with adherence rates ≥ 80%; 38 (46%) patients were classified as non-adherent to the monthly benzapen, with rates less than 80%. The mean adherence level was 70.12% (SD 29.25) and the median level was 83.30%, with a range of 0–100%; 27 (33%) patients had extremely poor adherence levels of ≤ 60%. Factors associated with adherence: higher education status, residing near health facility favoured high adherence, while painful injection was a major reason among poor performers. CONCLUSION: The level of non-adherence was significantly high (46%). Residence in a town/city and having at least a secondary level of education was associated with better adherence, while the painful nature of the benzapen injections and lack of transport money to travel to the health centre were the main reasons for non-adherence among RHD patients in Mulago. Clinics Cardive Publishing 2013-06 /pmc/articles/PMC3721822/ /pubmed/24217043 http://dx.doi.org/10.5830/CVJA-2013-022 Text en Copyright © 2010 Clinics Cardive Publishing http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cardiovascular Topics
Musoke, Charles
Mondo, Charles Kiiza
Zhang, Wanzhu
Freers, Juergen
Okello, Emmy
Kakande, Barbara
Nyakoojo, Wilson
Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital
title Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital
title_full Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital
title_fullStr Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital
title_full_unstemmed Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital
title_short Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital
title_sort benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending mulago hospital
topic Cardiovascular Topics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721822/
https://www.ncbi.nlm.nih.gov/pubmed/24217043
http://dx.doi.org/10.5830/CVJA-2013-022
work_keys_str_mv AT musokecharles benzathinepenicillinadherenceforsecondaryprophylaxisamongpatientsaffectedwithrheumaticheartdiseaseattendingmulagohospital
AT mondocharleskiiza benzathinepenicillinadherenceforsecondaryprophylaxisamongpatientsaffectedwithrheumaticheartdiseaseattendingmulagohospital
AT zhangwanzhu benzathinepenicillinadherenceforsecondaryprophylaxisamongpatientsaffectedwithrheumaticheartdiseaseattendingmulagohospital
AT freersjuergen benzathinepenicillinadherenceforsecondaryprophylaxisamongpatientsaffectedwithrheumaticheartdiseaseattendingmulagohospital
AT okelloemmy benzathinepenicillinadherenceforsecondaryprophylaxisamongpatientsaffectedwithrheumaticheartdiseaseattendingmulagohospital
AT kakandebarbara benzathinepenicillinadherenceforsecondaryprophylaxisamongpatientsaffectedwithrheumaticheartdiseaseattendingmulagohospital
AT nyakoojowilson benzathinepenicillinadherenceforsecondaryprophylaxisamongpatientsaffectedwithrheumaticheartdiseaseattendingmulagohospital